A fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company’s fund assets used for administrative, management, advertising, and other expenses.
| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 1 year | ₹60,000 | ₹61,293 | +2.15% | |
| 3 years | ₹1,80,000 | ₹2,61,168 | +45.09% | |
| 5 years | ₹3,00,000 | ₹5,23,664 | +74.55% | |
| 10 years | ₹6,00,000 | ₹15,22,206 | +153.70% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.64% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 7.05% |
| Max Healthcare Institute Ltd. | Healthcare | Equity | 5.24% |
| Lupin Ltd. | Healthcare | Equity | 4.44% |
| Laurus Labs Ltd. | Healthcare | Equity | 3.89% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.86% |
| Acutaas Chemicals Ltd. | Healthcare | Equity | 3.85% |
| Cipla Ltd. | Healthcare | Equity | 3.79% |
| Lonza Group Ag | Healthcare | ADS/ADR | 3.63% |
| Biocon Ltd. | Healthcare | Equity | 3.16% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 3.14% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 3.10% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.09% |
| Aether Industries Ltd. | Chemicals | Equity | 3.02% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.97% |
| Abbott India Ltd. | Healthcare | Equity | 2.91% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 2.76% |
| Poly Medicure Ltd. | Healthcare | Equity | 2.67% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 2.67% |
| Gland Pharma Ltd. | Healthcare | Equity | 2.59% |
| Concord Biotech Ltd. | Healthcare | Equity | 2.43% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 2.12% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 2.08% |
| Sudeep Pharma Ltd. | Healthcare | Equity | 1.92% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | Equity | 1.60% |
| Cohance Lifesciences Ltd. | Healthcare | Equity | 1.59% |
| Pfizer Ltd. | Healthcare | Equity | 1.25% |
| Medplus Health Services Ltd. | Healthcare | Equity | 1.01% |
| Nephrocare Health Services Ltd. | Healthcare | Equity | 0.92% |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | Equity | 0.85% |
| Gufic Biosciences Ltd. | Healthcare | Equity | 0.84% |
| CORONA Remedies Ltd. | Healthcare | Equity | 0.51% |
| Reserve Bank of India | Financial | T-Bills | 0.07% |
Average of the yearly returns of a mutual fund over a given period.
The total return of a mutual fund over a given period.
| Name | 3Y | 5Y | 10Y | All |
|---|---|---|---|---|
| Fund returns | +24.4% | +16.7% | +12.9% | +17.2% |
| Category average (Equity Sectoral) | +22.1% | +14.6% | +12.0% | -- |
| Rank (Equity Sectoral) | 2 | 2 | 4 | -- |
A fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company's fund assets used for administrative, management, advertising, and other expenses.
A percentage of your capital gains payable to the government upon exiting your mutual fund investments. Taxation is categorized as long-term capital gains (LTCG) and short-term capital gains (STCG) depending on your holding period and the type of fund.
A fee payable to a mutual fund house for exiting a fund (fully or partially) before the completion of a specified period from the date of investment.
A form of tax payable for the purchase or sale of an asset or security.